Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000574942 | SCV000664198 | likely benign | Hereditary cancer-predisposing syndrome | 2016-08-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000870640 | SCV001012161 | likely benign | Rhabdoid tumor predisposition syndrome 2 | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003322791 | SCV004028259 | uncertain significance | not provided | 2023-02-16 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 32686686) |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003322791 | SCV004221256 | likely benign | not provided | 2022-11-22 | criteria provided, single submitter | clinical testing |